FDA Advocates Single Phase III/IV Trial For Accelerated Approval Oncologics
This article was originally published in The Pink Sheet Daily
Executive Summary
Interim analysis of accelerated confirmatory trials could improve Phase IV completion rates, Office of New Drugs Medical Officer Vicki Goodman says at DIA annual meeting.